Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: A pilot study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
We hypothesized that atomoxetine (ATMX) would produce similar brain effects in attention-deficit/hyperactivity disorder (ADHD) as those of methylphenidate (MPH). Eleven ADHD adults performed the Multi-Source Interference Task (MSIT) during fMRI at baseline and after 6 weeks of ATMX treatment. ATMX was associated with increased fMRI activation of dorsolateral prefrontal cortex, parietal cortex and cerebellum; but not dorsal anterior midcingulate cortex (daMCC). These results suggest that ATMX and MPH have similar but non-identical brain effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473 · cited 1×
“While a few studies have provided insights (Arnsten, 2006; Seneca et al., 2006; Logan et al., 2007; Pliszka, 2007; Chamberlain et al., 2009; Takano et al., 2009), the neural mechanisms by which ATMX exerts therapeutic effects remain unresolved.”
Spencer, T., Biederman, J., Wilens, T., Doyle, R., Surman, C., Prince, J., Mick, E., Aleardi, M., Herzig, K., & Faraone, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.043 · Cited by 385
Self-citationArnsten, A. F. T. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00005 · Cited by 371
Attention-Deficit/Hyperactivity Disorder and Attention Networks
Bush, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.120 · Cited by 358 · cited 1×
“The data show that ATMX was associated with increased activation of DLPFC, parietal cortex, caudate, and cerebellum—brain regions implicated in attention, motor control and the pathophysiology of ADHD (Bush, 2010).”
Self-citationBush, G., & Shin, L. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.48 · Cited by 309 · cited 2×
“MSIT procedures (Bush and Shin, 2006; Bush et al., 2008) are summarized in Supplemental Figure 1.”
Self-citationCingulate, Frontal, and Parietal Cortical Dysfunction in Attention-Deficit/Hyperactivity Disorder
Bush, G. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.022 · Cited by 304 · cited 1×
“…in ADHD pathophysiology, including the dorsal anterior midcingulate (daMCC), dorsolateral prefrontal (DLPFC), and parietal cortices (together, the cingulo-frontal-parietal [CFP] cognitive-attention network), along with striatum and cerebellum (Paloyelis et al., 2007; Bush, 2009; Bush, 2011).”
Self-citationBiederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., Dunkel, S., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.011 · Cited by 267
Self-citationHannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236
Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J., Makris, N., Surman, C., Aleardi, M., Mick, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.16 · Cited by 201 · cited 13×
“MSIT procedures (Bush and Shin, 2006; Bush et al., 2008) are summarized in Supplemental Figure 1.”
InfluentialSelf-citationFunctional MRI in ADHD: a systematic literature review
Paloyelis, Y., Mehta, M. A., Kuntsi, J., & Asherson, P. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.10.1337 · Cited by 171
Cited by
Imaging the ADHD brain: disorder-specificity, medication effects and clinical translation
Rubia, K., Alegria, A., & Brinson, H. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.907526 · Cited by 146
Rubia, K., Criaud, M., Wulff, M., Alegria, A., Brinson, H., Barker, G., Stahl, D., & Giampietro, V. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2018.11.055 · Cited by 111
“Similar upregulation effects on rIFC and other fronto-striatal areas and downregulation effects on posterior DMN regions and networks have also been observed with Atomoxetine (Bush et al., 2013; Cubillo et al., 2013, 2014; Lin and Gau, 2015; Schulz et al., 2012).”
Kowalczyk, O. S., Cubillo, A. I., Smith, A., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., & Rubia, K. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.139 · Cited by 63
Chou, T.-L., Chia, S., Shang, C.-Y., & Gau, S. S.-F. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.024 · Cited by 44
Lin, H.-Y., & Gau, S. S.-F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv094 · Cited by 37
“Beyond the prefrontal areas, 2-month treatment with atomoxetine modulates inhibitory control-related activation more extensively in the cortical regions in individuals with ADHD (Schulz et al., 2012; Bush et al., 2013).”
BackgroundMethodWang, X., Cao, Q., Wang, J., Wu, Z., Wang, P., Sun, L., Cai, T., & Wang, Y. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.11.003 · Cited by 21
Pan, N., Ma, T., Liu, Y., Zhang, S., Hu, S., Shekara, A., Cao, H., Gong, Q., & Chen, Y. (2024) · Psychological Medicine · doi:10.1017/s003329172400285x · Cited by 7
Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders
Venero, C. (2015) · Cognitive Enhancement · doi:10.1016/b978-0-12-417042-1.00010-3 · Cited by 4
Metadata
- Authors
- Bush, G., Holmes, J., Shin, L. M., Surman, C., Makris, N., Mick, E., Seidman, L. J., & Biederman, J.
- Venue
- Psychiatry Research: Neuroimaging
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 211
- Issue
- 1
- Pages
- 88-91
- ISSN
- 0925-4927 (ISSN-L)
- OpenAlex
- W2065777888
- Cited by
- 41
- References
- 12
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.